Passage Bio, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PASG, updated each market day.
PASG AI Sentiment
AI sees no strong directional signal for Passage Bio, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Passage Bio, Inc. Common Stock
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Sector
Exchange
Market Cap
$18,926,079
Cap Tier
Employees
24
Headquarters
PHILADELPHIA, PA
Listed Since
Feb. 28, 2020
Website
PASG Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PASG Volatility
Passage Bio, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
